New MRI method could spot oral cancer early in rare disease patients
NCT ID NCT07649031
First seen Jun 27, 2026 · Last updated Jul 02, 2026 · Updated 1 time
Summary
This study explores whether MRI scans can safely and accurately detect cancerous or precancerous mouth lesions in people with Fanconi Anemia, a rare genetic condition that raises cancer risk. Researchers will compare MRI results to standard biopsies in 80 adult participants. If successful, this non-invasive approach could reduce the need for painful tissue sampling and allow earlier detection.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FANCONI ANEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Minnesota
RECRUITINGMinneapolis, Minnesota, 55455, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a single drink reveal how alcohol triggers oral cancer?
- Gene therapy aims to fix bone marrow failure in fanconi anemia
- New transplant method aims to reduce complications in bone marrow failure patients
- New hope for rare cancer: targeted drug afatinib tested in fanconi anemia patients
- New drug combo aims to make bone marrow transplants safer for kids
- Could a natural compound help prevent cancer in a rare disease?